infectious-diseases

Documents about infectious-diseases

• Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic#121454ClinicalTrials.gov
• A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers#136434ClinicalTrials.gov
• Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations#145131Springer Nature OA
• Modeling the Public Health Impact of Introducing 4CMenB Vaccination for Infants in the Brazilian National Immunization Program#145135Springer Nature OA
• The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative#145137Springer Nature OA
• Prevalence of dhfr-dhps sextuple mutants and gametocyte-harboring quintuple mutants resistant to sulfadoxine-pyrimethamine among pregnant women in Mozambique#146539bioRxiv / medRxiv
• Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024-2025#148851bioRxiv / medRxiv
• Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda#158062ClinicalTrials.gov
• Infectious Diseases and Antimicrobial Resistance in the Gaza Strip: Epidemiological Drivers, Health System Disruptions, and Global Implications: A Narrative Review.#170768NCBI PubMed Central
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities#180353ClinicalTrials.gov
• Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers#217088ClinicalTrials.gov
• Rapid Fabrication of High-Strength, Water-Resistant Chitin Micro–Nanofiber Films as Bioplastics#224138Figshare
• Selective Oxidation of Cyanotoxins (Microcystins) by Peroxyacetyl Radical: Kinetic Studies and Mechanistic Considerations#224158Figshare
• Nile Blue Microsolvation Reveals Ion-Specific Lipid Binding#224159Figshare
• Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)#234480ClinicalTrials.gov
• A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)#238174ClinicalTrials.gov
• Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults#256937ClinicalTrials.gov
• Genomic characterization of chikungunya virus during the large 2025 outbreak in Sri Lanka reveals emergence of a distinct Indian Ocean lineage strain#303446bioRxiv / medRxiv
• Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.#314396ClinicalTrials.gov
• Infections in Burn Patients: Pathophysiology, Prevention, and Contemporary Therapeutic Strategies in the Era of Antimicrobial Resistance#355762Springer Nature OA
• Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies#355782Springer Nature OA
• Tocilizumab (TCZ) in New-onset Type 1 Diabetes#363523ClinicalTrials.gov
• Higher Population Coverage with Typhoid Conjugate Vaccine is Needed to Induce Herd Protection: Evidence from a Cluster-Randomized Trial in Urban Bangladesh#369733bioRxiv / medRxiv
• Performance of five risk stratification tools for paediatric pneumonia against WHO scores using data from the PediCAP trial in sub-Saharan Africa#373580bioRxiv / medRxiv
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160#407779ClinicalTrials.gov
• Identifying and Prioritizing Barriers to TB Prevention and Care in High-Burden Countries: A Community-Engaged Approach Using Best-Worst Scaling#414293bioRxiv / medRxiv
• Treatment patterns in relapsed/refractory marginal zone lymphoma: real-world evidence from seven countries#414741Figshare
• Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women#426636ClinicalTrials.gov
• Adenosine 5′-Carboxamide-Based Inhibitors of METTL1#440508Figshare
• Adenosine 5′-Carboxamide-Based Inhibitors of METTL1#440510Figshare
• District-level ecological analysis of the association between stunting and infectious diseases among children under 2 years in Rwanda, 2020-2024.#469409NCBI PubMed Central
• European Society of Clinical Microbiology and Infectious Diseases Study Group for Artificial Intelligence and Digitalisation consensus statements on key aspects in the interaction of clinical microbiologists and infectious disease specialists with general-purpose large language model-based systems: project protocol.#402662NCBI PubMed Central
• AI-BASED EARLY DETECTION AND SURVEILLANCE OF INFECTIOUS DISEASES IN PAKISTAN: A PUBLIC HEALTH DATA ANALYTICS APPROACH#20799DataCite
• Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults#67697ClinicalTrials.gov
• A review of drivers of emerging infectious diseases within the wildlife-human-domestic animal interface in the West Pacific Tropics.#121222PubMed
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults#121426ClinicalTrials.gov
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine#123540ClinicalTrials.gov
• Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy#123543ClinicalTrials.gov
• 2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada#151593bioRxiv / medRxiv
• Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults#184912ClinicalTrials.gov
• <p>Baseline characteristics of elderly patients with sepsis in the ICU.</p>#195586Figshare
• <p>Restricted cubic spline curve of the GV with delirium incidence.</p>#195589Figshare
• <p>S1 Fig. Determination of the optimal cutpoint for glycemic variability.</p>#195591Figshare
• <p>Joinpoint regression of the disease burden of asbestosis in China.</p>#195598Figshare
• <p>Joinpoint regression of asbestos-related cancers in China, 1990–2023.</p>#195604Figshare
• A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis#201810ClinicalTrials.gov
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults#208290ClinicalTrials.gov
• A Dibenzo‑p‑dioxin-Shaped New Chemotype of Glycopeptide Antibiotic Active against Drug-Resistant Pathogens#212919Figshare
• Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen#245369ClinicalTrials.gov
• Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections#245447ClinicalTrials.gov